In addition, OSR1 acts directly on SMAD2/3 and phosphorylates 223Thr in the SMAD2-linked region and 179Thr in the SMAD3-linked region, promoting TGF-β pathway signalling and breast cancer metastasis [115]. Here, SMAD3 is linked to breast carcinoma.